Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2011 Aug 27;20(11):1150–1158. doi: 10.1002/pds.2215

Table 3.

Overall Positive Predictive Value for GI Perforation

Total Identified Cases Based on Claims Database* Cases Included in Chart Review Validation Study Positive Predictive Value

Total Confirmed Unconfirmed

N N N N % (95% Confidence Interval)^
GI site
 Upper 244 27 27 0 100.0% (100% – 100%)
  Esophagus 28 5 5 0 100.0% (100% – 100%)
  Stomach 216 22 22 0 100.0% (100% – 100%)
 Lower 468 65 59 6 90.8% (90.0% – 96.5%)
  Small intestine 5 1 1 0 100.0% (100% – 100%)
  Large intestine 145 17 16 1 94.1% (71.3% – 100%)
  Unspecified
  lower GI 325 47 42 5 89.4% (76.9% – 96.5%)
 Overall 704 92 86 6 93.5% (86.3% – 97.6%)

Identified cases: GI perforation cases identified from Premier inpatient database based on algorithm identified in Table 1

Cases included in the validation study: GI perforation cases being validated using chart review data based on physicians’ independent review

*

Sum of individual codes may exceed count in broader categories as patients may have multiple codes

^

95% confidence intervals were approximated using the binomial distribution